You are here

Article Text

Article menu
Download PDFPDF
Editorial
Maintaining equity and reducing risk when prescribing valproate: we still have a way to go

https://doi.org/10.1136/pn-2022-003685

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter @tonymarson2

    • Contributors TM is the sole author.

    • Funding TM is a National Institute for Health Research (NIHR) senior investigator and also part funded by NIHR ARC North West Coast.

    • Disclaimer The views expressed in this article are those of the author(s) and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care.

    • Competing interests TM has given a lecture at a meeting sponsored by Sanofi, honorarium paid to University of Liverpool.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Other content recommended for you